Glycopyrrolate (Oral Inhalation) and Mogamulizumab-kpkc Intravenous
Determining the interaction of Glycopyrrolate (Oral Inhalation) and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate
Brand name: Cuvposa, GLYRX-PF, Robinul, Robinul Forte, Lonhala Magnair Starter Kit, Seebri Neohaler
Synonyms: Glycopyrrolate
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycopyrrolate (Oral Inhalation)-Molindone
- Glycopyrrolate (Oral Inhalation)-Mometasone (Oral Inhalation)
- Glycopyrrolate (Oral Inhalation)-Mometasone and Formoterol
- Glycopyrrolate (Oral Inhalation)-Mometasone and formoterol Inhalation
- Glycopyrrolate (Oral Inhalation)-Mometasone Cream
- Glycopyrrolate (Oral Inhalation)-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate (Systemic)
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate and Formoterol
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate and formoterol Inhalation
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate and indacaterol inhalation
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate Capsules for Inhalation
- Mogamulizumab-kpkc Intravenous-Glycopyrrolate inhalation